The protease-activated receptor 2 regulates pigmentation via keratinocyte-melanocyte interactions

被引:193
|
作者
Seiberg, M
Paine, C
Sharlow, E
Andrade-Gordon, P
Costanzo, M
Eisinger, M
Shapiro, SS
机构
[1] Johnson & Johnson CPWW, Skin Res Ctr, Skillman, NJ 08558 USA
[2] RW Johnson Pharmaceut Res Inst, Spring House, PA 19477 USA
关键词
PAR-2; keratinocyte; pigmentation; melanosome transfer;
D O I
10.1006/excr.1999.4692
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Close association exists between melanocytes, the pigment melanin-producing cells in the body, and their neighboring keratinocytes. Keratinocytes are the pigment recipients and skin pigmentation is the result of this interaction. While the chemical basis of melanin production (melanogenesis) is well documented, the molecular mechanism of melanosome transfer needs to be elucidated. We are now providing first evidence that the protease-activated receptor 2 (PAR-2) expressed on keratinocytes, but not on melanocytes, is involved in melanosome transfer and therefore may regulate pigmentation, Activation of PAR-2 with trypsin or with the peptide agonist SLIGRL induced pigmentation in both two- and three-dimensional cocultures of keratinocytes and melanocytes, but not in cocultures that were spatially separated, indicating the need for intimate cell-cell contact, Topical application of SLIGRL on human skin transplanted on SCID mice resulted in a visible skin darkening. Histological examination revealed increased deposits of melanin in the keratinocytes, Inhibition of PAR-2 activation by RWJ-50353, a serine protease inhibitor, resulted in depigmentation and changes in expression of melanogenic-specific genes, Keratinocyte-melanocyte contact was essential for this depigmenting effect, Topical application of this inhibitor induced lightening of the dark skin Yucatan swine, which was confirmed by histochemical analysis. The results presented here suggest a novel mechanism for the regulation of pigmentation, mediated by the activation or inhibition of the keratinocyte receptor PAR-2. (C) 2000 Academic Press.
引用
收藏
页码:25 / 32
页数:8
相关论文
共 50 条
  • [21] Vasodilation via protease-activated receptor-2 preserves in metabolic syndrome
    Maruyama, Kana
    Kagota, Satomi
    McGuire, John J.
    Iwata, Saki
    Wakuda, Hirokazu
    Yoshikawa, Noriko
    Nakamura, Kazuki
    Shinozuka, Kazumasa
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S167 - S167
  • [22] Conserved structure and adjacent location of the thrombin receptor and protease-activated receptor 2 genes define a protease-activated receptor gene cluster
    Kahn, M
    Ishii, K
    Kuo, WL
    Riper, M
    Connolly, A
    Shi, YP
    Wu, R
    Lin, CC
    Coughlin, SR
    MOLECULAR MEDICINE, 1996, 2 (03) : 349 - 357
  • [23] Thrombin regulates the expression of proangiogenic cytokines via proteolytic activation of protease-activated receptor-1
    Naldini, A
    Carney, DH
    Pucci, A
    Pasquali, A
    Carraro, F
    GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 2000, 35 (05): : 255 - 259
  • [24] PARting Neuroinflammation with Protease-Activated Receptor 2 Pepducins
    Scarisbrick, Isobel A.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2024, 388 (01): : 8 - 11
  • [25] Role of protease-activated receptor 2 in joint inflammation
    Lam, Francis F. Y.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (11): : 3514 - 3517
  • [26] The protease activated receptor-2 upregulates keratinocyte
    Seiberg, M
    Sharlow, ER
    Paine, CS
    Babiarz, L
    Eisinger, MG
    Shapiro, SS
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 228A - 228A
  • [27] Expression of protease-activated receptor-2 by osteoblasts
    Abraham, LA
    Chinni, C
    Jenkins, AL
    Lourbakos, A
    Ally, N
    Pike, RN
    Mackie, EJ
    BONE, 2000, 26 (01) : 7 - 14
  • [28] INHIBITING PROTEASE-ACTIVATED RECEPTOR 2 ALLEVIATED PREECLAMPSIA
    Takahashi, Nobuyuki
    Ko, Mieko
    Oe, Yuji
    Fushima, Tomofumi
    Sekimoto, Akiyo
    Sato, Emiko
    Ito, Sadayoshi
    Sato, Hiroshi
    JOURNAL OF HYPERTENSION, 2016, 34 : E101 - E101
  • [29] PROTEASE-ACTIVATED RECEPTOR-2 AND RENAL CARCINOGENESIS
    Vesey, D.
    Rajandram, R.
    Blakeney, J.
    Suen, J.
    Johnson, D.
    Fairlie, D.
    Gobe, G.
    NEPHROLOGY, 2010, 15 : 91 - 91
  • [30] A Pathologic Role for Protease-Activated Receptor 2 in the Heart
    Antoniak, Silvio
    Spring, Denise
    Verrier, Edward D.
    Blaxall, Burns C.
    Mackman, Nigel
    Pawlinski, Rafal
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E197 - E198